NextMD

Blog

Insights on concierge medicine, direct primary care, and personalized healthcare.

Goldman Sachs Is Quietly Becoming One of The Most Important Investors in Concierge-Adjacent Healthcare

In eighteen months, the private equity (PE) and growth equity arms of Goldman Sachs Asset Management (GSAM) have made three large healthcare bets that are focused on a similar patient personality archetype. They co-own MDVIP , the largest concierge medicine network in the United States [1] They led the $150 million Series E for Aidoc, a foundation-model clinical artificial intelligence (AI) company whose software now reads scans across roughly 2,000 hospitals [3].

May 4, 2026

Goldman Sachs Is Quietly Becoming One of The Most Important Investors in Concierge-Adjacent Healthcare

House Call Doctors in 2026: How Concierge Practices Bring Medicine Back to Your Home

A Service That Disappeared, Then Came Back In 1930, roughly 40% of all doctor-patient encounters in the United States happened in the patient's home. By 1980, that figure had collapsed to under 1% [1].

May 3, 2026

House Call Doctors in 2026: How Concierge Practices Bring Medicine Back to Your Home

How to Find a Concierge Doctor Near You: A 2026 Step-by-Step Guide

If you need to see a traditional primary care doctor as a new patient you are often waiting an average of 24 days. This isn't even the worst part, when you arrive, you only get about seven minutes of face time[2].

May 2, 2026

How to Find a Concierge Doctor Near You: A 2026 Step-by-Step Guide

Concierge Medicine in the Los Angeles Metro: The 2026 Market Report

1. Executive Summary The Los Angeles metro is one of the two largest concierge medicine markets in the United States , (NYC LA have compete for the number 1 spot) NextMD lists 222 physician-led concierge and direct primary care (DPC) practices across greater LA, supported by 332 Doctor of Medicine (MD) and Doctor of Osteopathic Medicine (DO) physicians [1].

May 1, 2026

Concierge Medicine in the Los Angeles Metro: The 2026 Market Report

What Abridge's $300M Series E Means for Concierge Medicine

In April 2026, Abridge raised $300 million in a Series E round led by Andreessen Horowitz and Khosla Ventures, valuing the ambient artificial intelligence (AI) scribe company at $5.3 billion.

Apr 30, 2026

What Abridge's $300M Series E Means for Concierge Medicine

Concierge Medicine in the New York Metro: The 2026 Market Report

1. Executive Summary The New York metro is one of the top two concierge medicine markets in the United States , alongside greater Los Angeles.

Apr 29, 2026

Concierge Medicine in the New York Metro: The 2026 Market Report

What Is Retatrutide? A Patient's Guide for 2026

Retatrutide is an experimental once-weekly injectable being developed by Eli Lilly. In plain terms, it causes substantial fat loss while preserving more muscle than dieting alone.

Apr 28, 2026

What Is Retatrutide? A Patient's Guide for 2026

What Hippocratic AI's Voice Front Door Means for Concierge Medicine

In April 2026, Hippocratic AI launched two products that directly interact with patients. The first, called AI Front Door, is a voice agent that answers the phone, runs intake, and handles routine patient questions.

Apr 27, 2026

What Hippocratic AI's Voice Front Door Means for Concierge Medicine

The Doctor Shortage Hitting 30% of America: Why Concierge and DPC Became the Quiet Workaround

Nearly 30% of US adults do not have a usual source of primary care.[1] That is the highest level recorded in a decade.

Apr 26, 2026

The Doctor Shortage Hitting 30% of America: Why Concierge and DPC Became the Quiet Workaround

What Whoop's $575M Raise Means for Your Concierge Doctor

What Whoop's $575M Raise Means for Your Concierge Doctor In the first quarter of 2026, digital health startups raised $4.0 billion across 110 deals, the strongest first quarter since the pandemic funding peak.

Apr 25, 2026

What Whoop's $575M Raise Means for Your Concierge Doctor
Page 3 of 6